Home › Compare › ITMZF vs PFE

ITMZF vs PFE: Dividend Comparison 2026

ITMZF yields 181818.18% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ITMZF wins by $1.8951031795759825e+29M in total portfolio value
10 years
ITMZF
ITMZF
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full ITMZF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ITMZF vs PFE

📍 ITMZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodITMZFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ITMZF + PFE cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ITMZF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ITMZF
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ITMZF beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ITMZF + PFE for your $10,000?

ITMZF: 50%PFE: 50%
100% PFE50/50100% ITMZF
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ITMZF
No analyst data
Altman Z
-3.5
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ITMZF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricITMZFPFE
Forward yield181818.18% ✓6.13%
Annual dividend / share$2.00 ✓$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2% ✓
Portfolio after 10y$1.8951031795759825e+29M$49.6K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$26,258.71
Total dividends collected$1.8949690612486723e+29M$58.3K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ITMZF vs PFE ($10,000, DRIP)

YearITMZF PortfolioITMZF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$18,192,518$18,181,818.18$9,153$693.39+$18.18M → ITMZF
2$30,932,835,887$30,913,369,892.64$8,593$849.25+$30932.83M → ITMZF
3$49,156,619,660,049$49,123,521,525,649.34$8,336$1,066.78+$49156619.65M → ITMZF
4$73,009,768,971,452,110$72,957,171,388,415,860.00$8,437$1,384.80+$73009768971.44M → ITMZF
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$9,013$1,875.40+$101348671691011.75M → ITMZF
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$10,306$2,680.72+$131490628941834960.00M → ITMZF
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$12,820$4,101.38+$159445709700484431872.00M → ITMZF
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$17,673$6,826.70+$1.8070656065589233e+23M → ITMZF
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$27,543$12,591.86+$1.9141674430419936e+26M → ITMZF
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$49,560$26,258.71+$1.8951031795759825e+29M → ITMZF

ITMZF vs PFE: Complete Analysis 2026

ITMZF — Stock

React Gaming Group Inc. provides email marketing campaigns deployment and web services to large companies worldwide. It operates LOOT.BET, an online gaming and esports betting platform; and Compete.gg, a social gaming platform that allows users to engage in competitive events, tournaments, and 1v1 wagering. The company also operates Rainbow 6, Rocket League, Super Smash Bros Ultimate, CSGO, iRacing, and other teams; and influential fortnite team, as well as offers iGaming and esports platform solutions. It has a strategic partnership agreement with HealthCentric AI Inc. for the creation of an AI platform for the digital healthcare market. The company was formerly known as Intema Solutions Inc. and changed its name to React Gaming Group Inc. in April 2022. React Gaming Group Inc. was founded in 1994 and is headquartered in Saint-Laurent, Canada.

Full ITMZF Calculator →

PFE — Healthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ITMZF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ITMZF vs SCHDITMZF vs JEPIITMZF vs OITMZF vs KOITMZF vs MAINITMZF vs JNJITMZF vs MRKITMZF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.